Ci Investments Inc. Novo Cure LTD Transaction History

Ci Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $32,622 - $85,547	-2,020 Reduced 71.71%	797 $13,000
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $76,712 - $157,099	1,904 Added 208.54%	2,817 $117,000
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $42,781 - $90,057	758 Added 489.03%	913 $55,000
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $1,279 - $1,707	20 Added 14.81%	155 $11,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $203 - $268	-3 Reduced 2.17%	135 $10,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $17,885 - $28,408	-316 Reduced 69.6%	138 $10,000
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $1,563 - $2,197	-26 Reduced 5.42%	454 $38,000
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $6,832 - $11,101	91 Added 23.39%	480 $36,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $45,190 - $75,679	389 New	389 $45,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.